Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Incyte Corp banner

Incyte Corp
SWB:ICY

Watchlist Manager
Incyte Corp Logo
Incyte Corp
SWB:ICY
Watchlist
Price: 108.9 EUR -5.02% Market Closed
Market Cap: €24.5B
Write Note Create Alert

Intrinsic Value

Is ICY undervalued or overvalued?

See the intrinsic value estimate for Incyte Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

ICY Intrinsic Value
LOCKED
Unlock
Today vs. history

ICY looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with ICY’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor ICY
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price €108.9
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to ICY

Fundamental Analysis

What Incyte Does

Biotechnology Health Care

Incyte Corp is a biopharmaceutical company that discovers, develops, and sells prescription medicines, mainly for cancer and immune-related diseases. Its best-known products include treatments used by specialists in oncology and dermatology, where doctors prescribe the drugs to patients with conditions such as blood cancers, graft-versus-host disease, and inflammatory skin disorders.

Headquarters
United States of America US
Employees
2 844
IPO date
Dec 6, 1993
Read the full company overview
View Company Overview

Incyte has no economic moat

No Moat Narrow Wide

Incyte’s medicines face other treatments that doctors and patients can choose instead, and customers generally are not locked into using the company’s products. Patents can hold off copies for a time, but they do not protect the business indefinitely as other drugs compete for the same patients.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Incyte Corp

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

INCY Insider Trading
Buy and sell transactions by insiders

Continue ICY Research

Summary
ICY intrinsic value, competitors valuation, and company profile.
DCF Valuation
ICY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ICY stock valuation using valuation multiples.
Wall St Estimates
ICY price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ICY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Incyte Corp listings:
NASDAQ • USD
INCY
 LSE • USD
0J9P
 F • EUR
ICY
 XMUN • EUR
ICY
 DUS • EUR
ICY
Discover More
What is the Intrinsic Value of one ICY stock?

The intrinsic value for Incyte Corp (ICY) under the Base Case is hidden EUR.

Is ICY stock undervalued or overvalued?

Compared with the current market price of 108.9 EUR, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 362,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.